“Pass on the Pill or Pass Out” Campaign Warns Women About Addyi

0
558

“The National Women’s Health Network launched the ‘Pass on the Pink Pill – Or Pass Out’ campaign, to warn women of the marginal benefits and serious side effects of the new ‘pink pill’ as drug sales begin. Flibanserin, branded as Addyi – alleged to boost female libido was recently approved by the FDA and bought by Valeant Pharmaceuticals for $1 billion. Valeant is a pharmaceutical giant known for price gouging and shady business practices. Rather than rely on drug company marketing, NWHN recommends that women educate themselves and pass on the pink pill.”

Article →

pass on the pill campaign

LEAVE A REPLY